07971459383

Change Language

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

Bortezomib Injection I.P.

Name: Bortezomib Injection I.P.
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 2806.80 INR
Availability: InStock

Price 2806.80 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Bortezomib Injection I.P. Specification

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Bortezomib

Indication
Multiple Myeloma, Mantle Cell Lymphoma

Dosage Form
Lyophilized Powder

Origin of Medicine
India

Packaging Type
Vial

Life Span
24 months

Brand Name
Myezom

Drug Type
Allopathic

Ingredients
Bortezomib

Physical Form
Injection

Function
Anti Cancer

Recommended For
Hospital

Dosage
2 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C

Appearance
White to off-white powder

Prescription Status
Prescription Only

Trade Name
MYEZOM

Reconstitution Required
Yes

Strength Per Vial
2 mg/vial

Therapeutic Class
Oncology

Marketed By
Dr. Reddy's

Administration Route
IV or Subcutaneous

Bortezomib Injection I.P. Trade Information

Minimum Order Quantity
1 Vial

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India,

Bortezomib Injection I.P. About

Experience access to affordable cancer care with MYEZOM (Bortezomib Injection I.P.), a sensational and trending solution from Dr. Reddy's. Formulated as a splendiferous white to off-white lyophilized powder, each 2 mg/vial is suitable for intravenous or subcutaneous administration after reconstitution. As a prescription-only anti-cancer agent, MYEZOM is designed for adults and delivers gorgeous efficacy in treating both multiple myeloma and mantle cell lymphoma. This allopathic injection ensures quality and reliability, with a 24-month shelf life. Store below 25C for optimal preservation. Available exclusively for hospitals, MYEZOM offers premier oncology support from a trusted Indian exporter, supplier, and trader.

Versatile Application for Advanced Oncology Care

Bortezomib Injection I.P. (MYEZOM) is specifically designed for adult cancer patients, to be administered via intravenous or subcutaneous routes. It necessitates reconstitution before use, ensuring precise dose delivery. Its main material feature-being a lyophilized powder-provides superior stability and extended shelf life. Indicated for multiple myeloma and mantle cell lymphoma, MYEZOM serves as a reliable choice for hospital-based anti-cancer therapy, with usage directed under the careful guidance of a physician.

Certifications, Sampling, and Swift Delivery-All in One Outlay

MYEZOM comes with certifications confirming its origin and compliance with international standards, enhancing trust in its efficacy and safety. Samples for evaluation are available on request, facilitating informed procurement decisions for hospitals and practitioners. The asking price is competitive considering its premium oncology function. Efficient packing & dispatch ensure a streamlined delivery process, with prompt shipment upon order placement and careful packaging to maintain product integrity throughout transit.

FAQ's of Bortezomib Injection I.P.:

Q: How should Bortezomib Injection I.P. (MYEZOM) be administered?

A: MYEZOM is administered either intravenously (IV) or subcutaneously, depending on your physician's recommendation. Proper reconstitution is needed prior to administration.

Q: What conditions is MYEZOM indicated to treat?

A: MYEZOM is primarily indicated for adult patients with multiple myeloma and mantle cell lymphoma as prescribed by a healthcare professional.

Q: When should MYEZOM be used and who prescribes it?

A: MYEZOM should only be used under the direction and prescription of a licensed physician specializing in oncology, following diagnosis and treatment planning.

Q: Where should MYEZOM (Bortezomib) be stored prior to use?

A: Store MYEZOM below 25C to maintain product stability and effectiveness until ready for reconstitution and administration.

Q: What is the process for obtaining a sample or making a bulk purchase of MYEZOM?

A: Hospitals or practitioners can request a sample through the supplier or exporter, with details on certifications and packing & dispatch provided to ensure quality and prompt delivery.

Q: What are the key benefits of using MYEZOM over other injectable therapies?

A: MYEZOM offers affordable access to trending, high-quality oncology treatment, backed by certifications, long shelf life, and trusted efficacy for multiple myeloma and mantle cell lymphoma.